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Cell-penetrating peptides (CPPs), such as the HIV TAT peptide, are
able to translocate across cellular membranes efficiently. A number
of mechanisms, from direct entry to various endocytotic mechan-
isms (both receptor independent and receptor dependent), have
been observed but how these specific amino acid sequences ac-
complish these effects is unknown. We show how CPP sequences
can multiplex interactions with the membrane, the actin cytoske-
leton, and cell-surface receptors to facilitate different translocation
pathways under different conditions. Using “nunchuck” CPPs, we
demonstrate that CPPs permeabilize membranes by generating
topologically active saddle-splay (“negative Gaussian”) membrane
curvature through multidentate hydrogen bonding of lipid head
groups. This requirement for negative Gaussian curvature con-
strains but underdetermines the amino acid content of CPPs. We
observe that in most CPP sequences decreasing arginine content
is offset by a simultaneous increase in lysine and hydrophobic
content. Moreover, by densely organizing cationic residues while
satisfying the above constraint, TAT peptide is able to combine
cytoskeletal remodeling activity with membrane translocation ac-
tivity. We show that the TAT peptide can induce structural changes
reminiscent of macropinocytosis in actin-encapsulated giant vesi-
cles without receptors.
protein transduction domain ∣ polyarginine ∣ peptide-lipid interactions ∣
pore-forming peptide ∣ antimicrobial peptide
Cell-penetrating peptides (CPPs) are effective intracellulardelivery systems (1–5). These peptides are usually short (<20
amino acids) and cationic. Examples include the TAT peptide
from HIV, antennapedia (ANTP) from Drosophila, and even
simple polyarginines. Although unique molecular architectures
incorporating CPPs have been designed for drug delivery (3,
6–8), the molecular mechanisms of cellular entry, and the rela-
tions between them, are not well understood. Different uptake
mechanisms have been proposed for CPPs (9). Cell-based assays
have indicated that multiple endocytotic pathways are involved
(10–15). In addition to these, CPPs are also capable of direct
entry mechanisms* (17–20). In general, cell-penetrating activity
of CPPs has proven to be difficult to eliminate completely using a
specific set of conditions (3, 12, 21), suggesting the existence of
multiple mechanisms. A unified understanding of CPPs, which is
currently lacking, must engage why the same sequence can readily
activate the qualitatively distinct outcomes.
How do relatively simple molecules like HIV TAT peptide
facilitate mechanisms as different as direct translocation, and
multiple endocytotic processes? Rather than debate priority
between mechanisms, we focus on the physical chemistry of what
these different mechanisms and CPPs have in common. Here, we
show how the TAT peptide can multiplex different interactions
with the same sequence, thus interacting with the membrane,
the actin cytoskeleton, and specific receptors to produce multiple
pathways of translocation under different conditions. Although
it has been previously shown that TAT peptide can generate
negative Gaussian membrane curvature that is conducive to dif-
ferent types of membrane translocation activity (22), the micro-
scopic mechanism for curvature generation is not known, and
no direct experimental tests are available. Nor is it known how
different amino acids in a heterogeneous sequence collectively
induce this type of curvature. For example, why do hydrophobic
amino acids occur in some CPPs but not others? With fluores-
cence microscopy, we show the sensitivity of CPPs to changes in
hydrophobicity: The addition of a single hydrophobic residue to
purely hydrophilic CPPs can drastically modify the translocation
mechanism. To investigate explicitly the role of peptide-induced
membrane curvature strain, synchrotron X-ray scattering studies
on a series of synthetic “nunchuck” CPPs were performed.
Results reveal that the induced negative Gaussian curvature
necessary for translocation can be turned on or off by controlling
the organization of lipid head groups. Further, we find that the
topological requirement for negative Gaussian curvature places
constraints on the amino acid composition of CPPs, and we iden-
tify a trend relating arginines, lysines, and hydrophobic residues
that is consistent with most CPP sequences. Importantly, because
the requirements for pore formation underdetermine the full
sequences of CPPs, there is significant sequence flexibility for
taking on additional functions. The dense packing of cationic re-
sidues in TAT peptide allows it to not only optimize electrostatic
interactions with proteoglycan receptors but also with the actin
cytoskeleton. We show why the TAT peptide does not need
receptors to induce endocytosis. By incubating with the TAT pep-
tide, giant unilamellar vesicles (GUVs) with active encapsulated
cytoskeletons but no receptors for endocytosis can be restruc-
tured into morphologies reminiscent of those in blebbing and
macropinocytosis. Thus, the TAT peptide is able to multiplex
interactions with different cellular components that allow it to
induce direct membrane translocation, and to mediate endocyto-
sis with or without receptors.
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Results and Discussion
CPPs with hydrophobic residues (or hydrophobic cargo) act differ-
ently on membranes than those without. R6 (unlabeled to elimi-
nate contributions from hydrophobic dyes) mediated permeation
of GUVs that was sufficiently fast to rupture the GUV (Fig. 1 A
and B), because there is no supporting cytoskeleton that can corral
and stabilize the membrane. Similar results were observed for
unlabeled TAT peptide. In contrast, the addition of a single tryp-
tophan hydrophobic residue in R6W (unlabeled) resulted in slow
leakage from a full vesicle to an empty intact vesicle, reminiscent of
behavior of many antimicrobial peptides (AMPs) (Fig. 1 C andD).
The same was observed for R6 attached to hydrophobic cargo,
in this case fluorescein (R6-FITC), a dye rich in aromatic rings
(Fig. 1 E and F). After the encapsulated dye is leaked out, further
addition of R6-FITC results in the peptide traversing the GUV
membrane and the peptide concentration equilibrating across it.
This behavior is similar to that observed for labeled TAT peptide
and R6 added to GUVs with no encapsulated dye. These results
suggest that inclusion of a single hydrophobe drastically impacts
translocation in R6. R6 with no hydrophobicity is able to cross the
membrane quickly through transient pore-like structures, leading
to rapid lysis of vesicles. The addition of hydrophobicity, however,
stabilizes pores that allow for the leakage of the encapsulated dye
without destroying vesicles. These results illustrate the sensitivity of
CPPs to small changes in hydrophobicity and help reconcile the
diverse range of observations for CPP-induced vesicle leakage,
even for apparently similar experimental conditions (23–25).
To understand how changes in the CPP sequence (such as the
addition of hydrophobicity) impinge on the translocation mechan-
ism, we use polyarginine (polyR), the simplest prototypical CPP.
Rather than directly solving the structure of a CPP-induced pore,
we map out the conditions under which CPPs induce topologically
active membrane curvature using small-angle X-ray scattering
(SAXS). When exposed to R6 (Fig. 2A), small unilamellar vesicles
(SUVs) underwent a drastic structural transition and displayed
characteristic correlation peaks with ratios
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indicate the formation of a cubic Pn3m “double-diamond” lattice
(Fig. 2A) with lattice parameter a ¼ 13.3 nm. This is consistent
with the behavior of the TAT peptide (22). The Pn3m is a bicon-
tinuous cubic phase where two nonintersecting water channels are
separated by a lipid bilayer (26). The bilayer traces out a minimal
surface with saddle-splay curvature at every point, indicating that
each constituent monolayer also has saddle-splay curvature at
every point, the type of curvature necessary for “hole” formation
in a membrane (Fig. 2D). Saddle-shaped surfaces are found inside
“donuts,” which have a single hole each, but not on the surfaces of
spheres, which lack holes. In addition to pore formation, negative
Gaussian (or equivalently saddle-splay) curvature is a necessary
condition for processes such as blebbing, which is observed in
macropinocytosis.
At present, it is not clear how negative Gaussian curvature
derives from membrane interactions with specific peptide se-
quences. It is known that charged polymers can induce electro-
static wrapping by oppositely charged membranes (27–29), so
cationic peptides (e.g., polyarginine and polylysine) naturally gen-
erate negative mean curvature via induced electrostatic wrapping
of the peptide by anionic cell membranes. The guanidinium side
group in arginines can form multidentate hydrogen bonds with the
phosphates of lipid head groups and associate with multiple lipid
molecules (22, 30, 31). We hypothesize that this multidentate
hydrogen bonding creates positive curvature buckling strain, which
in combination with negative curvature strain along an orthogonal
direction from electrostatic interactions, generates saddle-splay
curvature (Fig. 2B). In contrast, the amino group in lysine forms
monodentate hydrogen bonds and therefore generates only nega-
tive curvature from electrostatic interactions (Fig. 2C). To test
this hypothesis, we investigated a series of artificial nunchuck
CPPs based on two tetraarginine (R4) blocks connected by flexible
PEG spacer chains of different lengths, so that the amount of
positive curvature strain can be continuously varied. For lipid–
peptide complexes made using CPPs with short PEG spacers
(RPEG-5), the Pn3m phase was preserved, albeit at a larger lattice
constant (a ¼ 17.5 nm), consistent with decreased saddle-splay
curvature: The average induced saddle-splay curvature of
RPEG-5 is hki ¼ 2.1 × 10−4 Å−2, which is less than that from R9
ðhki ¼ 3.7 × 10−4 Å−2Þ. As the spacer length was increased
(RPEG-27), the saddle-splay rich Pn3m structure was completely
lost, replaced by a coexistence of a lamellar (Lα) phase with
d ¼ 8.7 nm (which corresponds to the sum of the bilayer thickness
and diameter of the PEG spacer), and an inverted hexagonal
(HII) phase, with a lattice constant of 8.0 nm, which is similar to
the HII lattice constant for R4 alone (7.7 nm). These results show
that the amount of saddle-splay curvature generated and the re-
sultant propensity for inducing pore-like structures are controlled
by the multidentate H-bonding induced strain. Interestingly, if
we track how the average induced saddle-splay curvature varies
with the number of arginine repeats (NR) in polyR, we see that
it is maximized at NR ¼ 9 (Fig. 2E), where cell-penetrating activity
of polyR is highest from empirical observation (1, 32), with lower
activity at significantly higher or lower peptide lengths.
Saddle-splay curvature was induced in similar CPPs, including
polyR (a ¼ 13.3 nm for NR ¼ 9), HIV TAT (a ¼ 10.7 nm), and
ANTP (a ¼ 15.9 nm) (Fig. 2F), consistent with the topological
requirement for pore formation. In fact, generation of saddle-
splay membrane curvature necessitates specific amino acid com-
positions in pore-forming peptides. As previously demonstrated,
lipid head-group organization by arginine and lysine generates
Fig. 1. Mechanism of membrane permeation depends on peptide sequence. (A and B) R6 (unlabeled) added to 20∕60∕20 PS∕PE∕PC GUVs (red) with
encapsulated Alexa Fluor 633 dye (blue) induced permeation fast enough to rupture vesicles. (C and D) Addition of a single tryptophan hydrophobic residue
drastically changed the dominant mode of translocation/escape: R6W (unlabeled) induced slow leakage of intact vesicles, similar to antimicrobial peptides.
(E and F) Labeling R6 with the hydrophobic aromatic rings of fluorescein isothiocyanate (FITC, green) also gave rise to slow leakage of encapsulated dye,
followed by eventual equilibrium distribution of the R6-FITC peptide (G). White scale bars are 20 μm.
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distinct types of membrane curvature deformations. Arginine
simultaneously creates positive and negative curvatures along the
two perpendicular principal directions (negative Gaussian curva-
ture), whereas lysine creates negative curvature along one direc-
tion only. Hydrophobic amino acids create positive curvature by
inserting into the membrane (33–35). This implies a compensa-
tory relation between arginines and lysines/hydrophobes, as in
AMPs (36), and illustrated in a comparison between the amino
acid content of CPPs and AMPs. Fig. 2G shows a plot of NR∕
ðNR þ NK Þ (the ratio of the number of arginines to the sum of
the number of arginines and lysines) vs. hydrophobicity as mea-
sured by the Eisenberg hydrophobicity scale. A strong trend
consistent with this saddle-splay curvature selection rule can be
clearly discerned in CPPs and AMPs, as both are capable of
membrane permeation. The TAT peptide, which has two lysine
residues, illustrates this rule. According to the selection rule, TAT
peptide needs some hydrophobicity to balance the lysines. TAT
peptide, in fact, has two hydrophobic amino acids. This allows the
TAT peptide to generate more Gaussian curvature compared to
R9, even though it has six arginines rather than nine, as shown
by the lattice constants (10.7 nm vs. 13.3 nm, Fig. 2F).
Why is the hydrophobic content of the TAT peptide relatively
low if hydrophobicity can help generate negative Gaussian
curvature? A key difference between CPPs and AMPs is that the
former systematically use fewer hydrophobic residues (and con-
comitantly more arginines) to generate saddle-splay curvature
(Fig. 2G). This difference in sequences can potentially decrease
the extent of membrane insertion and lead to shorter pore life-
times for CPPs. This hypothesis is consistent with the behavior
of R6 variants in Fig. 1. A comparison between TAT peptide and
R6 is instructive. For R6, the addition of a single strong hydro-
phobe (one strong hydrophobe per seven amino acids) is able to
change the observed translocation mechanism from the fast to
the slow mode. TAT peptide is almost twice as long as R6. More-
over, TAT peptide has one strong hydrophobe and one that is
quite weak. We have seen that unlabeled TAT peptide is capable
of fast translocation, although not quite as fast as the R6. By add-
ing one strong hydrophobic fluorescent dye to its sequence, TAT
peptide has two strong hydrophobes in 12 residues (or one strong
hydrophobe per six amino acids). The proportion of hydrophobic
residues is now actually comparable to that of R6W and a slow
dye leakage is observed, consistent with published experiments
(25, 37, 38).
We hypothesize that the difference between peptides that kill
and those that do not may be a time scale of the induced mem-
brane deformation. CPPs only induce transient pore-like translo-
cation structures in the membrane, perhaps reminiscent of those
observed in recent simulations (39, 40), rather than the stable
pores of AMPs.
The ability to generate saddle-splay membrane curvature is
inherent in the sequences of CPPs. Such curvature is broadly
enabling and is also evident in the dimples formed in caveolae-
based endocytosis and in the cytoskeleton-driven protrusions in
macropinocytosis (9). Moreover, CPPs are able to generate sad-
dle-splay curvature in membranes even when incubated at 4 °C,
consistent with direct translocation observed at low temperatures.
Although induction of saddle-splay curvature accounts for the
existence of direct translocation across cell membranes, it is not
a sufficient condition for full CPP activity. We observed that
carboxytetramethylrhodamine (TAMRA)-labeled TAT peptide
Fig. 2. Membrane activity of CPPs controlled by lipid crowding effects and amino acid content. (A) SAXS data for R9, incubated with SUVs
(DOPS∶DOPE ¼ 20∶80) at peptide-to-lipid molar ratio ðP∕LÞ ¼ 1∕40 show diffraction peak positions well described by q ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðh2 þ k2 þ l2Þ∕a
p
, characteristic
of a bicontinuous cubic Pn3m phase (h, k, l are Miller indices; a is the lattice parameter). Tetraarginine blocks connected with a short PEG spacer
(R4-ðPEGÞ5-R4) induces a Pn3m phase ðP∕L ¼ 1∕40Þ with a larger lattice constant. SAXS data for R4-ðPEGÞ27-R4, with a longer PEG spacer, show that the
Pn3m phase is suppressed, replaced by HII and Lα phases with no saddle-splay curvature ðP∕L ¼ 1∕40Þ. (B) Multidentate coordination of arginine’s guanidinium
side chain induces positive curvature strain along the peptide. (C) Monodentate coordination of lysine’s amino side chain does not induce positive curvature.
(D) The cubic Pn3m phase (the zero-mean-curvature surface at the midplane between the two membrane leaflets) (E) The average induced Gaussian curvature
hkið¼ 2πχ∕a2Ao; χ ¼ −2 and Ao ¼ 1.919 for Pn3m) is maximized near NR ¼ 9, where observed membrane transduction activity is empirically highest. (F) ANTP,
TAT peptide, R9 all induce the cubic Pn3m phase in membranes (DOPS∶DOPE ¼ 20∶80 at P∕L ¼ 1∕40). (G) The ratio of the number of arginines to the number of
arginines + number of lysines ðNR∕ðNR þ NKÞÞ plotted against hydrophobicity (Eisenberg hydrophobicity scale) using the amino acid sequences of 39 cell-
penetrating peptides and 1080 cationic antimicrobial peptides shows that a reduction in arginine content can be compensated for by an increase in both
lysine and hydrophobic content.
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(TAMRA-TAT) readily crossed the membranes of GUVs and
the peptide concentration equilibrated across the membrane
(Fig. 3A). However, the same was not true for TAT peptide con-
jugated to nanoparticles. We attached polylactide (PLA) nano-
particles (approximately 30 nm in diameter) stained with Cy5
dye to the TAT peptide (TAT-NP). TAT-NPs were unable to enter
vesicles (Fig. 3B). The enhanced fluorescence intensity at the
lipid bilayer indicated aggregation of TAT-NPs around the per-
iphery of GUVs. The TAT peptide, although conjugated to the
nanoparticles, is still able to induce negative Gaussian membrane
curvature and permeabilize the membrane. TAT-NPs added to
GUVs with encapsulated G-actin allowed Mg2þ ions to cross
the membrane and polymerize actin (Fig. 3 C and D). These
results suggest that large TAT-NPs are anchored to a perforated
membrane but are not directly translocated, and require an
endocytotic process for cellular uptake. This indicates that the
debate of direct entry vs. endocytosis is not a simple “either-or”
question with distinct and exclusive outcomes and is influenced by
factors such as size of attached cargo. The above result shows that
it is possible for the TAT peptide to perforate the membrane
and anchor a large payload to it, but not translocate across the
membrane. This leads to the question of how TAT peptide pro-
motes endocytotic uptake of large cargos, as observed in cell-
based studies (5, 11, 41).
There is significant sequence flexibility in TAT peptide to
develop additional functions, such as binding to receptors to the
cytoskeleton, because the requirement for generating negative
Gaussian curvature (Fig. 2) underdetermines the full CPP se-
quence, as stated above. The charge density of TAT peptide (lin-
ear charge density λT ¼ þ1e∕4.5 Å) closely matches the charge
density of cell-surface heparan sulfate proteoglycans (HSPG,
λH ∼ −1e∕5 Å), which are known receptors for endocytosis (42,
43). Electrostatic attractions in water are especially strong when
the charged surfaces have comparable charge densities, due to
the resultant maximal entropy gain of counterion release (44, 45).
Indeed, thermodynamic studies show that the TAT peptide has
significant affinity toward heparin sulfate (46, 47); studies using
cells treated with chemicals that eliminate HSPGs or using mu-
tant cells that are unable to synthesize proteoglycans have shown
a significant reduction in TAT peptide internalization (13, 15, 48).
However, recent studies have demonstrated transduction of
TAT peptide even in mutant cells deficient in glycosaminoglycans
(49, 50). These results suggest that even though cell-surface pro-
teoglycans constitute an internalization pathway other indepen-
dent pathways also exist.
Macropinocytosis has been suggested as a receptor-indepen-
dent endocytosis mechanism for cellular uptake of TAT peptide
(11, 49, 51), although the details are not completely clear. Macro-
pinocytosis is a receptor-independent pathway for endocytosis
that begins with outwardly directed growth of actin filaments
that ultimately results in internalization of objects within large
endocytotic vesicles (macropinosomes). Because the CPP inter-
nalization pathway depends on ambient conditions (3, 52, 53),
we have performed experiments (see SI Text) to confirm that
actin polymerization inhibitors significantly reduce CPP uptake
levels under our experimental conditions, to compare with exist-
ing trafficking experiments (10, 11, 51): These results demon-
strate the importance of actin polymerization in TAT activity,
consistent with the existence of a parallel endocytotic pathway,
but they do not indicate how endocytosis is achieved in the
absence of receptors. Moreover, it is not clear how TAT peptide
induces the observed actin accumulation and remodeling at the
cell periphery (10, 54, 55).
At present, it is not known how the TAT peptide can nonspe-
cifically induce actin remodeling. We note that CPPs are highly
cationic with a charge density beyond the Manning limit (56, 57),
which allows them to interact directly and strongly with the actin
cytoskeleton. In fact, the cationic charge of the TAT peptide can
efficiently interact with both heparan sulfate proteoglycans and
filamentous actin (F-actin) ðλA ¼ −1e∕2.5 ÅÞ, leading to strong
attractive interactions. The former allows for receptor-mediated
endocytosis as noted above, but the latter allows something
previously undescribed. In order to eliminate the influence of all
potential receptors for endocytosis, we investigated TAT pep-
tide’s interactions with an active actin cytoskeleton encapsulated
inside a GUVwith divalent ion channels. Such channels provide a
steady supply of Mg2þ ions to maintain a high level of dynamic
actin polymerization inside the GUVs. In the absence of TAT
peptide, no significant membrane deformations were observed
(Fig. 4A). When these actin-encapsulated GUVs were exposed to
TAT peptide (unlabeled), they underwent drastic shape transi-
tions, reminiscent of “ruffling” and “fingering” deformations in
cells (Fig. 4 B andC). In some cases, the actin network even broke
symmetry and deformed the spherical vesicle into elongated
structures (Fig. 4D). Collectively, these induced cytoskeletal
changes are similar to those that occur in macropinocytosis.
Moreover, in vitro results show that in addition to membrane
effects, TAT peptide can also directly induce actin polymerization
and bundle formation (SI Text). We hypothesize that the bundling
of actin filaments reduces the number of contact points and con-
centrates the forces between the polymerizing actin and the mem-
brane leading to observed membrane distortions (Fig. 4 B–D),
which is similar to those observed for encapsulated microtubules
(58). These results indicate that the TAT peptide can enhance
membrane deformation and cytoskeleton reorganization neces-
sary for endocytotic processes, even in a minimal model. The
striking morphological changes in the vesicle observed above may
also explain the puzzling observation that addition of free TAT
peptide enhances the transfection efficiencies of TAT-DNA com-
plexes (59). The free TAT peptide can cross the membrane and
induce membrane ruffling and blebbing that promotes internali-
zation of objects bound to the membrane surface.
That CPPs can interact with the actin cytoskeleton directly
suggests an interesting comparison with AMPs. Many AMPs have
biological functions besides membrane permeation. For example,
Fig. 3. The induction of saddle-splay curvature alone is not a sufficient
condition for full strength CPP activity. (A) TAMRA-labeled TAT peptide
(TAMRA-TAT; red) readily crossed the membrane of PS∶PC∶PE ¼ 20∶40∶40
GUVs. (B) TAT peptide covalently coupled to Cy5-tagged PLA nanoparticles
(TAT-NP, approximately 30-nm diameter, blue) did not cross the membrane
but were localized at the periphery of GUVs. (C) PS∶PC∶PE ¼ 20∶40∶40 GUVs
loaded with G-actin and rhodamine phalloidin (red). (D) TAT-NPs (blue),
added to these GUVs and localized at the periphery, were able to induce ne-
gative Gaussian membrane curvature and membrane permeation, enabling
Mg2þ ions to cross GUV membrane and polymerize the encapsulated G-actin
into F-actin bundles (red). White scale bars are 10 μm.
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indolicidin (60), buforin (61), and tachyplesin (62) are also known
to bind internal targets in bacteria such as DNA. In analogy to our
arguments on CPPs, the amino acid composition criterion for
generation of negative Gaussian membrane curvature underde-
termines AMP sequences (36), so they are also able to optimize
their sequences to bind to highly cationic biopolymers, in this case
DNA rather than F-actin. When viewed in this way, CPPs are a
special case of AMPs that specialize in short lifetime pores and
cytoskeletal interactions.
Conclusion
Because the amino acid composition requirements for strong
CPP-cytoskeleton and CPP-membrane interactions can be simul-
taneously satisfied, the TAT peptide can multiplex interactions
to effect either direct translocation through the membrane or
mediate endocytosis with or without receptors. We propose a
general model for TAT peptide-mediated cellular transduction
(Fig. 4E). The TAT peptide can bind to HSPG and get interna-
lized via normal endocytosis pathways. It can also interact with
the membrane to generate saddle-splay curvature and induce
pore-like structures. If the cargo attached to the TAT peptide is
small, it can be translocated directly. Cargos larger than a few
nanometers do not get directly translocated but are anchored to
the membrane by the TAT peptide. The existence of strong TAT-
actin interactions on the cytoplasmic side can remodel the cytos-
keleton, thus promoting alternate cellular uptake mechanisms
like macropinocytosis.
Materials and Methods
Peptide Synthesis. TAT protein transduction domain (Tyr-Gly-Arg-Lys-Lys-
Arg-Arg-Gln-Arg-Arg-Arg), R4 [ðArgÞ4], RPEG-5 [ðArgÞ4-ðPEGÞ5-ðArgÞ4], and
RPEG-27 [ðArgÞ4-ðPEGÞ27-ðArgÞ4] were synthesized using automated solid-
state synthesis. R6 [ðArgÞ9] and TAMRA-labeled TAT were purchased from
Anaspec, Inc. The R34, R46, and R60 polypeptides were synthesized as poly
(ϵ-CBZ-L-lysine) chains of the desired lengths using transition metal-initiated
α-amino acid N-carboxyanhydride polymerization using ðPMe3Þ4Co. The
primary amines on lysine were converted to guanidinium groups using an
excess of the reagent 3,5-dimethyl-1-pyrazolylformaminidium nitrate as
described elsewhere (6).
SUV Preparation. The lipids 1,2-Dioleoyl-sn-glycero-3-[phospho-L-serine]
(sodium salt) (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphocholine, and 1,2-dio-
leoyl-sn-glycero-3-phosphoethanolamine (DOPE) were purchased from
Avanti Polar Lipids, Inc. and were used without further preparation. Lipid
solutions in chloroform were dried under N2 and desiccated under vacuum
overnight. The dried lipids were rehydrated with Millipore water to a final
concentration of 20 mg∕mL at 37 °C overnight, sonicated, and extruded
through a 0.2-μm nucleopore (Whatman, Inc.) filter. Peptides dissolved in
Millipore water at 5 mg∕mLweremixedwith SUVs at specific peptide-to-lipid
molar ratios and salt conditions and sealed in quartz capillaries.
Synchrotron X-Ray Scattering. SAXS data were collected at Stanford Synchro-
tron Radiation Laboratory (BL4-2), Advanced Light Source (BL 7.3.3), and
Advanced Photon Source (BESSRCAT BL-12ID) using 9 keV, 10 keV, and 12 keV
X-rays, respectively. The scattered intensity was collected using a MAR-
Research charge-coupled device detector (pixel size 79 μm). All experiments
were conducted at room temperature. Representative samples were remea-
sured after several months to ensure that they were fully equilibrated.
Arginine/(Arginine + Lysine) Ratio vs. hHydrophobicityi. The sequences of
39 CPPs were compared against those of 1,080 cationic AMPs. For a given
peptide, j, its average hydrophobicity is defined by
hhydrophobicityij ≡
1
n∑
n
i¼1
wi;
where n ¼ number of amino acids in the peptide and wi ¼ the
hydrophobicity of the ith amino acid in the peptide as set by the Eisenberg
hydrophobicity scale. The range of hhydrophobicityi was divided into 20
equal bins in the case of CPPs and into 100 equal bins in the case of AMPs.
For the M peptides in a given bin,
NR
RR þ NK
≡ ∑
M
j¼1ðnumber of RÞj
∑
M
j¼1ðnumber of RÞj þ∑
M
j¼1ðnumber of KÞj
:
NR∕ðNR þ NKÞ was plotted vs. hhydrophobicityi for each of the bins to see
the trend.
Confocal Microscopy. GUVs labeled with DiO/DiI (Invitrogen) were prepared
using electroformation. Lipid mixtures in chloroform were deposited and
desiccated on indium tin oxide-coated glass slides, before swelling with
sucrose (100 mM) solution containing Alexa Fluor 546∕633 succinimidyl ester
dyes (approximately 1 kDa at approximately 5 μM, pretreated with Tris)
under 10-Hz ac electric field. After GUV detachment via 4-Hz square ac, the
suspension was diluted into glucose (100 mM) and NaCl (100 mM) solution
and imaged in a 200-μL chamber with a Leica TCS SP2 laser scanning confocal
microscope (63×, 1.4 N.A. immersion objective).
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Fig. 4. TAT peptide can penetrate membranes and actively induce cytoskeletal actin response. (A) Confocal image of a GUV comprising 40∕40∕20 PE∕PC∕PS
(labeled green with DiO) with 5% calcium ionophore (Calcimycin) and encapsulating 7 μM globular actin (G-actin). Exposure to 8 mMMg2þ, diffusing into the
GUV via the ionophores, induced polymerization into filamentous actin (F-actin, labeled red with rhodamine phallodin) network without any accompanying
deformation of vesicle. (B and C) Exposure to approximately 4 μM TAT peptide-induced dimple instabilities on the membrane, and promoted growth of F-actin
bundles encapsulated within the GUV. (D) In certain cases, the F-actin bundles distorted originally spherical vesicles to form sharp filopodium-like protusions,
reminiscent of membrane ruffling and macropinocytosis. (E) Schematic showing a proposed autonomous pathway for TAT cellular transduction. TAT peptide
can generate saddle-splay membrane curvature and enter through an induced pore, but large conjugated cargos cannot. The TAT peptide interacts strongly
with cytoplasmic actin to promote cellular uptake of anchored cargo via endocytotic pathways. White scale bars are 10 μm.
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